<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8816395" created="07/01/20" creator="Yumiko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8816395</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Requirements for induction of <term id="T1" lex="vitamin_D-mediated_gene_regulation" sem="Other"><term id="A1" sem="Organic_compound_other">vitamin D</term>-mediated <term id="A2" sem="DNA_domain_or_region">gene</term> regulation</term> in <term id="T2" lex="normal_human_B_lymphocyte" sem="Cell_natural">normal human B lymphocytes</term>.</sentence>
<event KT="Other" id="E1">
<type class="Regulation"/>
<theme idref="A2"/>
<cause idref="A1"/>
<clue>Requirements for induction of vitamin D-<linkCause>mediated</linkCause> gene <clueType>regulation</clueType> <clueLoc>in normal human B lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<clue>Requirements for <clueType>induction</clueType> <linkTheme>of</linkTheme> vitamin D-mediated gene regulation <clueLoc>in normal human B lymphocytes</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Regulation"/>
<theme idref="E2"/>
<clue><clueType>Requirements</clueType> <linkTheme>for</linkTheme> induction of vitamin D-mediated gene regulation <clueLoc>in normal human B lymphocytes</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="A3" sem="Cell_natural">Mature <term id="T3" lex="human_lymphocyte" sem="Cell_natural">human lymphocytes</term></term> are unique targets of <term id="T4" lex="1_alpha,25-dihydroxyvitamin_D3" sem="Lipid">1 alpha,25-dihydroxyvitamin D3</term> (<term id="T5" lex="1_alpha,25(OH)2D3" sem="Lipid">1 alpha,25(OH)2D3</term>) in that <term id="T6" lex="vitamin_D_receptor" sem="Protein_family_or_group">vitamin D receptors</term> (<term id="T7" lex="VDR" sem="Protein_family_or_group">VDR</term>) are not constitutively expressed, and specific <term id="A4" sem="Organic_compound_other">cellular activation signals</term> are required for both the up-regulation of <term id="T8" lex="VDR" sem="Protein_family_or_group">VDR</term> and establishment of reactivity to the <term id="T9" lex="lipophilic_ligand" sem="Lipid">lipophilic ligand</term>.</sentence>
<event KT="Other" id="E4">
<type class="Cell_differentiation"/>
<theme idref="T3"/>
<clue><clueType>Mature</clueType> human lymphocytes are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are required for both the up-regulation of VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="A3"/>
<cause idref="T5"/>
<clue>Mature human lymphocytes are unique <clueType>targets</clueType> <linkCause>of</linkCause> 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are required for both the up-regulation of VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E6">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue><clueLoc>Mature human lymphocytes</clueLoc> are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are <cluePolarity>not</cluePolarity> constitutively <clueType>expressed</clueType>, and specific cellular activation signals are required for both the up-regulation of VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>Mature human lymphocytes are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are required for both the <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<event KT="Other" id="E9">
<type class="Binding"/>
<theme idref="T8"/>
<theme idref="T9"/>
<clue>Mature human lymphocytes are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are required for both the up-regulation of VDR and establishment of <clueType>reactivity</clueType> <linkTheme>to</linkTheme> the lipophilic ligand.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="A4"/>
<clue><clueLoc>Mature human lymphocytes</clueLoc> are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are <clueType>required</clueType> <linkTheme>for</linkTheme> both the up-regulation of VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="A4"/>
<clue><clueLoc>Mature human lymphocytes</clueLoc> are unique targets of 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) in that vitamin D receptors (VDR) are not constitutively expressed, and specific cellular activation signals are <clueType>required</clueType> <linkTheme>for</linkTheme> both the up-regulation of VDR and establishment of reactivity to the lipophilic ligand.</clue>
</event>
<sentence id="S3">Treatment of <term id="T10" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term> with the <term id="T11" lex="cytokine" sem="Protein_family_or_group">cytokine</term> <term id="T12" lex="IL-4" sem="Protein_molecule">IL-4</term> (<term id="T13" lex="IL-4" sem="Protein_molecule">IL-4</term>), in the absence of prior activation, induces a weak up-regulation of <term id="T14" lex="VDR_expression" sem="Other"><term id="T15" lex="VDR" sem="Protein_family_or_group">VDR</term> expression</term> but fails to generate <term id="T16" lex="vitamin_D-responsive_element_(VDRE)-reactive_nuclear_protein_complex" sem="Protein_complex"><term id="T17" lex="vitamin_D-responsive_element" sem="DNA_domain_or_region">vitamin D-responsive element</term> (<term id="T18" lex="VDRE" sem="DNA_domain_or_region">VDRE</term>)-reactive <term id="A6" sem="Protein_complex">nuclear protein complexes</term></term> or to initiate the genomic transcription of <term id="T19" lex="25-hydroxyvitamin_D3_24-hydroxylase" sem="Protein_molecule">25-hydroxyvitamin D3 24-hydroxylase</term>.</sentence>
<event KT="Method" id="E12">
<type class="Artificial_process"/>
<theme idref="T10"/>
<theme idref="T13"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> B lymphocytes <linkTheme>with</linkTheme> the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR expression but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E13">
<type class="Physiological_process"/>
<theme idref="T10"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the <cluePolarity>absence</cluePolarity> of prior <clueType>activation</clueType>, induces a weak up-regulation of VDR expression but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR <clueType>expression</clueType> but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event Manner="Low" id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a <clueManner>weak</clueManner> <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> VDR expression but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E12"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, <clueType>induces</clueType> a weak up-regulation of VDR expression but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Protein_metabolism"/>
<theme idref="T16"/>
<cause idref="E12"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR expression but <cluePolarity>fails</cluePolarity> to <clueType>generate</clueType> vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event KT="Other" id="E17">
<type class="Correlation"/>
<theme idref="T18"/>
<theme idref="A6"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR expression but fails to generate vitamin D-responsive element (VDRE)-<clueType>reactive</clueType> nuclear protein complexes or to initiate the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Other" id="E18">
<type class="Transcription"/>
<theme idref="T19"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR expression but fails to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to initiate the genomic <clueType>transcription</clueType> <linkTheme>of</linkTheme> 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E12"/>
<clue>Treatment of B lymphocytes with the cytokine IL-4 (IL-4), in the absence of prior activation, induces a weak up-regulation of VDR expression but <cluePolarity>fails</cluePolarity> to generate vitamin D-responsive element (VDRE)-reactive nuclear protein complexes or to <clueType>initiate</clueType> the genomic transcription of 25-hydroxyvitamin D3 24-hydroxylase.</clue>
</event>
<sentence id="S4">Stimulation of <term id="T20" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term> by either ligation of <term id="T21" lex="CD40_Ag" sem="Protein_molecule">CD40 Ag</term> or cross-linking the <term id="T22" lex="Ig_receptor" sem="Protein_family_or_group">Ig receptor</term> is also insufficient to render <term id="T23" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term> responsive to <term id="T24" lex="1_alpha,25(OH)2D3" sem="Lipid">1 alpha,25(OH)2D3</term>.</sentence>
<event id="E7">
<type class="Binding"/>
<theme idref="T20"/>
<theme idref="T22"/>
<clue>Stimulation of B lymphocytes by either ligation of CD40 Ag or <clueType>cross-linking</clueType> the Ig receptor is also insufficient to render B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<event id="E54">
<type class="Binding"/>
<theme idref="T20"/>
<theme idref="T21"/>
<clue>Stimulation of B lymphocytes by either <clueType>ligation</clueType> <linkTheme>of</linkTheme> CD40 Ag or cross-linking the Ig receptor is also insufficient to render B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<event id="E21">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="E7"/>
<clue><clueType>Stimulation</clueType> <linkTheme>of</linkTheme> B lymphocytes <linkCause>by</linkCause> either ligation of CD40 Ag or cross-linking the Ig receptor is also insufficient to render B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<event id="E22">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="E54"/>
<clue><clueType>Stimulation</clueType> <linkTheme>of</linkTheme> B lymphocytes <linkCause>by</linkCause> either ligation of CD40 Ag or cross-linking the Ig receptor is also insufficient to render B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<event KT="Other" id="E23">
<type class="Correlation"/>
<theme idref="T23"/>
<theme idref="T24"/>
<clue>Stimulation of B lymphocytes by either ligation of CD40 Ag or cross-linking the Ig receptor is also insufficient to render B lymphocytes <clueType>responsive</clueType> <linkTheme>to</linkTheme> 1 alpha,25(OH)2D3.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="E21"/>
<clue>Stimulation of B lymphocytes by either ligation of CD40 Ag or cross-linking the Ig receptor is also <cluePolarity>insufficient</cluePolarity> to <clueType>render</clueType> B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="E22"/>
<clue>Stimulation of B lymphocytes by either ligation of CD40 Ag or cross-linking the Ig receptor is also <cluePolarity>insufficient</cluePolarity> to <clueType>render</clueType> B lymphocytes responsive to 1 alpha,25(OH)2D3.</clue>
</event>
<sentence id="S5">However, this apparent lack of response to the <term id="T25" lex="secosterol" sem="Lipid">secosterol</term> can be overcome by stimulation of <term id="T26" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term> with a combination of these <term id="A8" sem="Organic_compound_other">cellular activation signals</term>, which are sufficient to lead to <term id="T27" lex="G1_cell_cycle_progression" sem="Other"><term id="A7" sem="Other">G1 cell cycle</term> progression</term>.</sentence>
<event CL="L2" KT="Analysis" id="E28">
<type class="Regulation"/>
<theme idref="E24"/>
<cause idref="E26"/>
<clue>However, <corefTheme>this apparent lack of response to the secosterol</corefTheme> <clueKT><clueCL>can</clueCL></clueKT> be <clueType>overcome</clueType> <linkCause>by</linkCause> stimulation of B lymphocytes with a combination of these cellular activation signals, which are sufficient to lead to G1 cell cycle progression.</clue>
</event>
<event CL="L2" KT="Analysis" id="E27">
<type class="Regulation"/>
<theme idref="E24"/>
<cause idref="E26"/>
<clue>However, <corefTheme>this apparent lack of response to the secosterol</corefTheme> <clueKT><clueCL>can</clueCL></clueKT> be <clueType>overcome</clueType> <linkCause>by</linkCause> stimulation of B lymphocytes with a combination of these cellular activation signals, which are sufficient to lead to G1 cell cycle progression.</clue>
</event>
<event id="E26">
<type class="Physiological_process"/>
<theme idref="T26"/>
<cause idref="E30"/>
<clue>However, this apparent lack of response to the secosterol can be overcome by <clueType>stimulation</clueType> <linkTheme>of</linkTheme> B lymphocytes <linkCause>with</linkCause> a combination of these cellular activation signals, which are sufficient to lead to G1 cell cycle progression.</clue>
</event>
<event id="E30">
<type class="Correlation"/>
<theme idref="T21"/>
<theme idref="T22"/>
<clue>However, this apparent lack of response to the secosterol can be overcome by stimulation of B lymphocytes with a <clueType>combination</clueType> <linkTheme>of</linkTheme> <corefTheme>these cellular activation signals</corefTheme>, which are sufficient to lead to G1 cell cycle progression.</clue>
</event>
<event id="E31">
<type class="Cellular_physiological_process"/>
<theme idref="A7"/>
<clue>However, this apparent lack of response to the secosterol can be overcome by stimulation of B lymphocytes with a combination of these cellular activation signals, which are sufficient to lead to G1 cell cycle <clueType>progression</clueType>.</clue>
</event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="E27"/>
<clue>However, this apparent lack of response to the secosterol can be overcome by stimulation of B lymphocytes with a combination of these cellular activation signals, which are <clueType>sufficient to lead</clueType> <linkTheme>to</linkTheme> G1 cell cycle progression.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="E28"/>
<clue>However, this apparent lack of response to the secosterol can be overcome by stimulation of B lymphocytes with a combination of these cellular activation signals, which are <clueType>sufficient to lead</clueType> <linkTheme>to</linkTheme> G1 cell cycle progression.</clue>
</event>
<sentence id="S6">In the presence of <term id="T28" lex="1_alpha,25(OH)2D3" sem="Lipid">1 alpha,25(OH)2D3</term>, <term id="A9" sem="Other">cellular activation</term> associated with stimulation of such a progression appears to be sufficient for the up-regulation of <term id="T29" lex="VDR_message" sem="RNA_family_or_group"><term id="T30" lex="VDR" sem="Protein_family_or_group">VDR</term> message</term> and <term id="A10" sem="Protein_family_or_group">protein</term> and necessary for the establishment of <term id="T31" lex="VDRE_binding_complex" sem="Protein_complex"><term id="T32" lex="VDRE" sem="DNA_domain_or_region">VDRE</term> binding complexes</term> and the induction of <term id="T33" lex="24-hydroxylase_message" sem="RNA_family_or_group"><term id="T34" lex="24-hydroxylase" sem="Protein_molecule">24-hydroxylase</term> message</term>.</sentence>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with <clueType>stimulation</clueType> <linkTheme>of</linkTheme> <corefTheme>such a progression</corefTheme> appears to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event KT="Analysis" id="E35">
<type class="Correlation"/>
<theme idref="A9"/>
<theme idref="E34"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> stimulation of such a progression appears to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event KT="Other" id="E36" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<cause idref="A9"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be <clueType>sufficient for the up-regulation</clueType> <linkTheme>of</linkTheme> VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
<comment>NER T29 MOD</comment></event>
<event KT="Other" id="E37" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T30" idref1="A10"/>
<cause idref="A9"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be <clueType>sufficient for the up-regulation</clueType> <linkTheme>of</linkTheme> VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event KT="Other" id="E38" uncertainty="probable">
<type class="Binding"/>
<theme idref="T32"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be sufficient for the up-regulation of VDR message and protein and necessary for the <clueType>establishment</clueType> <linkTheme>of</linkTheme> VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event KT="Other" id="E39" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the <clueType>induction</clueType> <linkTheme>of</linkTheme> 24-hydroxylase message.</clue>
<comment>NER T33 MOD</comment></event>
<event KT="Other" id="E40" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="A9"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be sufficient for the up-regulation of VDR message and protein and <clueType>necessary</clueType> <linkTheme>for</linkTheme> the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event KT="Other" id="E41" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A9"/>
<clue>In the presence of 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression appears to be sufficient for the up-regulation of VDR message and protein and <clueType>necessary</clueType> <linkTheme>for</linkTheme> the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
</event>
<event CL="L2" KT="Analysis" id="E42" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="T28"/>
<clue><linkCause>In the presence of</linkCause> 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression <clueKT><clueCL>appears</clueCL></clueKT> to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" id="E43" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T28"/>
<clue><linkCause>In the presence of</linkCause> 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression <clueKT><clueCL>appears</clueCL></clueKT> to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" id="E44" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E40"/>
<cause idref="T28"/>
<clue><linkCause>In the presence of</linkCause> 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression <clueKT><clueCL>appears</clueCL></clueKT> to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" id="E45" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E41"/>
<cause idref="T28"/>
<clue><linkCause>In the presence of</linkCause> 1 alpha,25(OH)2D3, cellular activation associated with stimulation of such a progression <clueKT><clueCL>appears</clueCL></clueKT> to be sufficient for the up-regulation of VDR message and protein and necessary for the establishment of VDRE binding complexes and the induction of 24-hydroxylase message.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S7">Furthermore, <term id="A11" sem="Other">biologic functions</term> are modulated, in that the <term id="A13" sem="Protein_family_or_group">hormone</term> inhibits proliferation in a <term id="A12" sem="Cell_natural">subset of the activated <term id="T35" lex="B_cell" sem="Cell_natural">B cells</term></term>.</sentence>
<event id="E46">
<type class="Regulation"/>
<theme idref="A11"/>
<clue>Furthermore, biologic functions are <clueType>modulated</clueType>, in that the hormone inhibits proliferation in a subset of the activated B cells.</clue>
</event>
<event id="E47">
<type class="Physiological_process"/>
<theme idref="T35"/>
<clue>Furthermore, biologic functions are modulated, in that the hormone inhibits proliferation in a subset of the <clueType>activated</clueType> B cells.</clue>
</event>
<event KT="Other" id="E48">
<type class="Cellular_physiological_process"/>
<theme idref="A12"/>
<clue>Furthermore, <clueTime>biologic functions are modulated</clueTime>, in that the hormone inhibits <clueType>proliferation</clueType> <linkTheme>in</linkTheme> a subset of the activated B cells.</clue>
<comment>TPS A12</comment></event>
<event id="E49">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="A13"/>
<clue>Furthermore, <clueTime>biologic functions are modulated</clueTime>, in that the hormone <clueType>inhibits</clueType> proliferation in a subset of the activated B cells.</clue>
</event>
<sentence id="S8">These observations suggest that reactivity to <term id="T36" lex="1_alpha,25(OH)2D3" sem="Lipid">1 alpha,25(OH)2D3</term> is tightly regulated in <term id="T37" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term>, requiring <term id="A14" sem="Organic_compound_other">specific signals</term> for its initiation.</sentence>
<event KT="Other" id="E50" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T36"/>
<clue>These observations suggest that <clueType>reactivity</clueType> <linkTheme>to</linkTheme> 1 alpha,25(OH)2D3 is tightly regulated in B lymphocytes, requiring specific signals for its initiation.</clue>
<comment>SENSITIVITY</comment></event>
<event CL="L2" KT="Analysis" Manner="High" id="E51" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E50"/>
<clue>These observations <clueKT><clueCL>suggest</clueCL></clueKT> that reactivity to 1 alpha,25(OH)2D3 is <clueManner>tightly</clueManner> <clueType>regulated</clueType> <clueLoc>in B lymphocytes</clueLoc>, requiring specific signals for its initiation.</clue>
</event>
<event KT="Other" id="E52" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<cause idref="A14"/>
<clue>These observations suggest that reactivity to 1 alpha,25(OH)2D3 is tightly regulated in B lymphocytes, <clueType>requiring</clueType> specific signals <linkTheme>for</linkTheme> its initiation.</clue>
</event>
<event KT="Other" id="E53">
<type class="Positive_regulation"/>
<theme idref="E51"/>
<clue>These observations suggest that reactivity to 1 alpha,25(OH)2D3 is tightly regulated in B lymphocytes, requiring specific signals for <corefTheme>its</corefTheme> <clueType>initiation</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
